{"nctId":"NCT03368066","briefTitle":"Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?","startDateStruct":{"date":"2018-01-29","type":"ACTUAL"},"conditions":["Adrenal Insufficiency","Cirrhosis","Spur Cell Anemia","Lecithin Acyltransferase Deficiency"],"count":100,"armGroups":[{"label":"Hospitalized cirrhosis patients","type":"EXPERIMENTAL","interventionNames":["Drug: Cosyntropin"]}],"interventions":[{"name":"Cosyntropin","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age \\>=18 years\n* Diagnosis of cirrhosis\n* Admission to hospital\n\nExclusion Criteria:\n\n* Age \\< 18 years\n* Prior enrollment in study (i.e. readmission)\n* Prisoner\n* Pregnancy\n* Prednisone or Hydrocortisone use in last 24 hours","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"110 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Cholesterol Esterification Deficiency","description":"A percent quantification of serum cholesterol esterification will be measured via blood draw. Low values represent deficiency in esterification, which is a surrogate measure of lecthicin-cholesterol acetyltransferase (LCAT) enzymatic deficiency.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"11","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Spur Cell Anemia","description":"A peripheral blood smear will be obtained and assessed for presence of acanthocytes (spur cells). Spur cell anemia is defined as a serum hemoglobin \\< 10g/dL and the presence of \\>= 5% spur cells on blood smear.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"8","spread":null}]}]}]},{"type":"PRIMARY","title":"Participant Transplant-Free Survival","description":"Transplant and Death are considered equivalent outcomes","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"41","spread":null},{"groupId":"OG001","value":"16","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Relative Adrenal Insufficiency (RAI)","description":"A baseline total cortisol level will be obtained and then patients will receive a standard-dose synthetic ACTH (250mcg of Cosyntropin) stimulation test to assess for the presence of adrenal insufficiency. RAI is defined as a change in the total cortisol level in response to the stimulation test of \\<9mcg/dL when measured 60 minutes after the Cosyntropin is administered.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"37","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Low Free Cortisol","description":"Patients will have their free cortisol levels measured to assess for deficiency.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Received Liver Transplantation at 90 Days","description":"Patients who received a liver transplant within 90 days of enrollment","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Received Liver Transplantation at 6 Months","description":"Patients who received a liver transplant within 6 months of enrollment","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"6","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Died Within Index Hospitalization","description":"Patients who died within the same hospitalization as enrollment","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Died at 30 Days","description":"Patients who died within 30 days of enrollment","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Died at 90 Days","description":"Patients who died within 90 days of enrollment","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Died at 6 Months","description":"Patients who died within 6 months of enrollment","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"15","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":25,"n":100},"commonTop":["Nausea"]}}}